1 January – 30 June (unaudited)
|
kEUR |
H1 2025 |
H1 2024 |
|
|
|
|
|
|
|
Result for the period |
|
-26,539 |
-11,386 |
|
|
|
|
|
|
Other comprehensive income to be reclassified to profit or loss in subsequent periods |
|
|
|
|
Exchange differences on translation of foreign operations, net of tax |
|
-2,437 |
-8,709 |
|
Net other comprehensive income to be reclassified to profit or loss in subsequent periods |
|
-2,437 |
-8,709 |
|
|
|
|
|
|
Other comprehensive income not to be reclassified to profit or loss in subsequent periods |
|
|
|
|
Remeasurement gain / (loss) on defined benefit plans |
|
2,866 |
-2,590 |
|
Income tax effect |
|
-626 |
626 |
|
Net other comprehensive income not to be reclassified to profit or loss in subsequent periods |
|
2,240 |
-1,964 |
|
Other comprehensive result for the period, net of taxes |
|
-197 |
-10,673 |
|
|
|
|
|
|
Total comprehensive result for the period, net of taxes |
|
-26,736 |
-22,059 |
|
|
|
|
|
|
Attributable to shareholders of PolyPeptide Group AG |
|
-26,736 |
-22,059 |